Bristol-Myers Squibb Co. (NYSE: BMY) on Monday, soared 1.39% from the previous trading day, before settling in for the closing price of $51.92. Within the past 52 weeks, BMY’s price has moved between $39.35 and $55.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 16.92%. The company achieved an average annual earnings per share of -90.63%. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.03 billion.
Considering the fact that the conglomerate employs 34100 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 70.79%, operating margin of 26.56%, and the pretax margin is -13.8%.
Bristol-Myers Squibb Co. (BMY) Insider Activity
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of Bristol-Myers Squibb Co. is 0.08%, while institutional ownership is 77.23%. The most recent insider transaction that took place on Dec 05 ’23, was worth 99,560. In this transaction Chief Executive Officer of this company bought 2,000 shares at a rate of $49.78, taking the stock ownership to the 82,672 shares. Before that another transaction happened on Nov 28 ’23, when Company’s Chief Executive Officer bought 3,071 for $48.86, making the entire transaction worth $150,049. This insider now owns 79,384 shares in total.
Bristol-Myers Squibb Co. (BMY) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 1.82 earnings per share (EPS) for the period topping the consensus outlook (set at 1.61) by 0.21. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.52 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -90.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -4.21% during the next five years compared to 5.14% growth over the previous five years of trading.
Bristol-Myers Squibb Co. (NYSE: BMY) Trading Performance Indicators
Bristol-Myers Squibb Co. (BMY) is currently performing well based on its current performance indicators. A quick ratio of 1.02 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.29. Likewise, its price to free cash flow for the trailing twelve months is 8.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit 1.49 in the next quarter and is forecasted to reach 6.97 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co. (BMY)
Compared to the last year’s volume of 14.52 million, its volume of 7.14 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 48.23%. Additionally, its Average True Range was 1.11.
During the past 100 days, Bristol-Myers Squibb Co.’s (BMY) raw stochastic average was set at 87.49%, which indicates a significant increase from 58.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.51% in the past 14 days, which was lower than the 29.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $50.81, while its 200-day Moving Average is $47.87. Nevertheless, the first resistance level for the watch stands at $52.99 in the near term. At $53.35, the stock is likely to face the second major resistance level. The third major resistance level sits at $53.94. If the price goes on to break the first support level at $52.05, it is likely to go to the next support level at $51.46. Should the price break the second support level, the third support level stands at $51.10.
Bristol-Myers Squibb Co. (NYSE: BMY) Key Stats
Market capitalization of the company is 106.72 billion based on 2,027,100K outstanding shares. Right now, sales total 45,006 M and income totals 8,025 M. The company made 12,201 M in profit during its latest quarter, and 1,680 M in sales during its previous quarter.
